Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or

Nasdaq 100 E-Mini Dec '24 (NQZ24)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CME]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ rootItem.symbol ]]underlying price [[ rootItem.lastPrice ]] [[ rootItem.priceChange ]] ([[ rootItem.percentChange ]]) [[ rootItem.tradeTime ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Nasdaq 100 E-Mini Futures Market News and Commentary

Stocks Settle Sharply Lower on the Outlook for Slower Fed Rate Cuts

The S&P 500 Index ($SPX) (SPY) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.70%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -2.40%.

Stocks retreated Friday, with the S&P 500 and Nasdaq 100 falling to 1-1/2 week lows and the Dow Jones Industrials falling to a 1-week low.  Signs of a hawkish Fed pushed the 10-year T-note yield to a 5-1/2 month high Friday and pressured stocks.  On Thursday, Fed Chair Powell signaled the Fed was in no hurry to cut interest rates.  Also, Boston Fed President Collins shared that view when she said Friday that a December interest rate cut by the Fed isn't a "done deal."  The hawkish Fed comments reduced the chances of a Fed rate cut next month to 58% from 82% a day ago.  Stocks added to their losses as bond yields rose further after today’s US economic news showed that retail sales and the Nov Empire manufacturing survey rose more than expected, a hawkish factor for Fed policy.

Vaccine makers... Read more

Contract Specifications

See More
Contract
E-Mini Nasdaq 100
Contract Size
$20 times Index
Tick Size
0.25 points ($5.00 per contact)
Trading Hours
5:00p.m. - 4:00p.m. (Sun-Fri) (Settles 3:00p.m.) CST
Exchange
CME
Point Value
$20
Margin/Maintenance
$24,420/22,200
First Notice Date
12/20/24 (33 days)
Expiration Date
12/20/24 (33 days)

Seasonal Chart

Nasdaq 100 E-Mini Dec '24
Average Price Chart for 5 Prior Dec Contracts

Commitment of Traders Positions as of Nov 12, 2024

View Chart Details
Commercials - Long / Short
156,585 (+12,005)
186,948 (+14,710)
Non-Commercials - Long / Short
71,007 (+8,223)
54,627 (+7,935)
Dealers / Intermediary - Long / Short
48,248 (+3,222)
113,620 (+7,672)
Asset / Manager - Long / Short
101,654 (+8,217)
24,693 (-1,246)
Leveraged Funds - Long / Short
39,192 (+2,348)
87,654 (+12,099)
Other Reportables - Long / Short
28,898 (+5,768)
6,008 (+3,447)
Get Realtime - Quotes and Charts for Futures Traders. Learn More >>

Price Performance

See More
Period Period Low Period High Performance
1-Month
20,008.50 +2.43%
on 10/31/24
21,340.75 -3.97%
on 11/11/24
+151.75 (+0.75%)
since 10/15/24
3-Month
18,562.00 +10.41%
on 09/06/24
21,340.75 -3.97%
on 11/11/24
+679.75 (+3.43%)
since 08/15/24
52-Week
16,572.00 +23.66%
on 12/06/23
21,340.75 -3.97%
on 11/11/24
+3,873.25 (+23.30%)
since 11/15/23

More Nasdaq 100 E-Mini Quotes

All Futures Prices
Please wait...

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on DaVita Stock?

While DaVita has outperformed the broader market over the past year, analysts on Wall Street are exercising caution regarding its future prospects.

XHS : 91.60 (-1.70%)
BCS : 13.21 (+1.93%)
$SPX : 5,870.62 (-1.32%)
DVA : 160.33 (+3.87%)
Are Wall Street Analysts Bullish on Dow Stock?

Although Dow has underperformed the broader market over the past year, analysts remain cautiously optimistic about its future prospects.

SHW : 378.99 (-2.26%)
$SPX : 5,870.62 (-1.32%)
DOW : 44.04 (-1.23%)
PIPR : 336.11 (+1.42%)
XLB : 91.28 (-0.70%)
Retirement Plan Contribution Limits and Deadlines for 2024

Everything you need to know about how much you can contribute to a variety of retirement plans, and when you need to contribute by, for the 2024 tax year.

What Are Wall Street Analysts' Target Price for Marathon Oil Stock?

With Marathon Oil underperforming the broader S&P 500 Index, Wall Street analysts remain cautiously optimistic about the stock.

XLE : 94.73 (-0.15%)
COP : 112.32 (-0.53%)
$SPX : 5,870.62 (-1.32%)
MRO : 28.59 (-0.52%)
Do Wall Street Analysts Like Fox Corporation Stock?

Fox Corporation has outperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

FOXA : 45.64 (-3.88%)
PEJ : 51.60 (-1.49%)
WFC : 74.34 (+2.12%)
$SPX : 5,870.62 (-1.32%)
GS : 593.54 (+0.84%)
Erie Indemnity Stock: Analyst Estimates & Ratings

Erie Indemnity has surged past the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

$SPX : 5,870.62 (-1.32%)
KIE : 59.40 (+0.39%)
ERIE : 405.00 (-0.27%)
Welltower Stock: Is Wall Street Bullish or Bearish?

Welltower has outperformed the broader market over the past year, yet Wall Street analysts appear cautiously optimistic about the stock’s outlook.

WFC : 74.34 (+2.12%)
VTR : 63.60 (+0.16%)
WELL : 136.02 (+1.19%)
$SPX : 5,870.62 (-1.32%)
VNQ : 93.80 (+0.05%)
What Are Wall Street Analysts' Target Price for C.H. Robinson Stock?

C.H. Robinson has beaten the broader market and its peers over the past year, but Wall Street’s optimism about its future comes with a dash of caution.

BCS : 13.21 (+1.93%)
CHRW : 110.19 (-1.16%)
$SPX : 5,870.62 (-1.32%)
SUPL : 41.19 (-0.44%)
Intellia Therapeutics Reports Promising Phase 1 Trial Results for Nexiguran Ziclumeran in ATTR Amyloidosis

Intellia Therapeutics announces positive Phase 1 trial results for nex-z in ATTR amyloidosis, indicating significant TTR reduction and disease stabilization.Quiver AI SummaryIntellia Therapeutics announced...

NTLA : 13.97 (-7.61%)
Cytokinetics Presents New Data on Omecamtiv Mecarbil from GALACTIC-HF Trial at AHA Scientific Sessions 2024

Cytokinetics presented new analyses on omecamtiv mecarbil's efficacy in heart failure at the AHA Scientific Sessions 2024.Quiver AI SummaryCytokinetics, Incorporated announced new findings from post-hoc...

CYTK : 50.22 (-8.19%)

Barchart Trading Guide

The Barchart Trading Guide is a Buy Signal with a Average Signal Strength.

Key Turning Points

3rd Resistance Point 21,424.67
2nd Resistance Point 21,203.08
1st Resistance Point 20,848.42
Last Price 20,493.75s
1st Support Level 20,272.17
2nd Support Level 20,050.58
3rd Support Level 19,695.92

See More

52-Week High 21,340.75
Last Price 20,493.75s
Fibonacci 61.8% 19,519.09
Fibonacci 50% 18,956.38
Fibonacci 38.2% 18,393.66
52-Week Low 16,572.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar